CHA₂DS₂VASc 和 R₂CHA₂DS₂VASc 评分预测 COVID-19 患者院内死亡率的比较

Konuralp Tıp Dergisi Pub Date : 2024-02-22 DOI:10.18521/ktd.1282982

Faruk Boyaci, M. Şahi̇n, Y.Bülent Boyaci, Ahmet Yanik, Gökhan Aksan

{"title":"CHA₂DS₂VASc 和 R₂CHA₂DS₂VASc 评分预测 COVID-19 患者院内死亡率的比较","authors":"Faruk Boyaci, M. Şahi̇n, Y.Bülent Boyaci, Ahmet Yanik, Gökhan Aksan","doi":"10.18521/ktd.1282982","DOIUrl":null,"url":null,"abstract":"Objectives: This study aims to compare of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients and find a new scoring system that can better predict the hospital mortality by adding some laboratory parameters to the CHA₂DS₂VASc and R₂CHA₂DS₂VASc scores. \nMethods: This is a cross-sectional study. A total of 1076 COVID-19 patients with confirmed COVID-19 PCR tests were included from September 2020 to March 2021. Age, sex, comorbidity, laboratory, survival times, and death status of the patients were recorded. The scores CHA₂DS₂VASc and R₂CHA₂DS₂VASc of each patient were calculated. A new mortality prediction score was created to establish the most effective model with logistic regression analysis, including laboratory values. \nResults: Of the 1076 patients hospitalized for COVID-19, 15.1% died, while 84.9% survived. There was no significant difference between the two groups in sex. All comorbidities were significantly higher in the deceased than in the survivors (p","PeriodicalId":174708,"journal":{"name":"Konuralp Tıp Dergisi","volume":"52 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 hastalarında hastane içi mortalitenin CHA₂DS₂VASc ve R₂CHA₂DS₂VASc skor tahmininin karşılaştırılması\",\"authors\":\"Faruk Boyaci, M. Şahi̇n, Y.Bülent Boyaci, Ahmet Yanik, Gökhan Aksan\",\"doi\":\"10.18521/ktd.1282982\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: This study aims to compare of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients and find a new scoring system that can better predict the hospital mortality by adding some laboratory parameters to the CHA₂DS₂VASc and R₂CHA₂DS₂VASc scores. \\nMethods: This is a cross-sectional study. A total of 1076 COVID-19 patients with confirmed COVID-19 PCR tests were included from September 2020 to March 2021. Age, sex, comorbidity, laboratory, survival times, and death status of the patients were recorded. The scores CHA₂DS₂VASc and R₂CHA₂DS₂VASc of each patient were calculated. A new mortality prediction score was created to establish the most effective model with logistic regression analysis, including laboratory values. \\nResults: Of the 1076 patients hospitalized for COVID-19, 15.1% died, while 84.9% survived. There was no significant difference between the two groups in sex. All comorbidities were significantly higher in the deceased than in the survivors (p\",\"PeriodicalId\":174708,\"journal\":{\"name\":\"Konuralp Tıp Dergisi\",\"volume\":\"52 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Konuralp Tıp Dergisi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18521/ktd.1282982\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Konuralp Tıp Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18521/ktd.1282982","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

研究目的本研究旨在比较CHA₂DS₂VASc和R₂CHA₂DS₂VASc评分对COVID-19例患者的住院死亡率，并通过在CHA₂DS₂VASc和R₂CHA₂DS₂VASc评分中加入一些实验室参数，找到一种能更好预测住院死亡率的新评分系统。研究方法这是一项横断面研究。从 2020 年 9 月至 2021 年 3 月，共纳入了 1076 名经 COVID-19 PCR 检测确诊的 COVID-19 患者。记录了患者的年龄、性别、合并症、实验室、生存时间和死亡状况。计算每位患者的 CHA₂DS₂VASc 和 R₂CHA₂DS₂VASc 分数。通过逻辑回归分析建立了一个新的死亡率预测评分，包括实验室数值，以建立最有效的模型。结果在因 COVID-19 住院的 1076 名患者中，15.1% 的患者死亡，84.9% 的患者存活。两组患者在性别上无明显差异。死亡患者的所有并发症均明显高于存活者（p

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

COVID-19 hastalarında hastane içi mortalitenin CHA₂DS₂VASc ve R₂CHA₂DS₂VASc skor tahmininin karşılaştırılması

Objectives: This study aims to compare of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients and find a new scoring system that can better predict the hospital mortality by adding some laboratory parameters to the CHA₂DS₂VASc and R₂CHA₂DS₂VASc scores. Methods: This is a cross-sectional study. A total of 1076 COVID-19 patients with confirmed COVID-19 PCR tests were included from September 2020 to March 2021. Age, sex, comorbidity, laboratory, survival times, and death status of the patients were recorded. The scores CHA₂DS₂VASc and R₂CHA₂DS₂VASc of each patient were calculated. A new mortality prediction score was created to establish the most effective model with logistic regression analysis, including laboratory values. Results: Of the 1076 patients hospitalized for COVID-19, 15.1% died, while 84.9% survived. There was no significant difference between the two groups in sex. All comorbidities were significantly higher in the deceased than in the survivors (p

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Konuralp Tıp Dergisi

自引率

0.00%

发文量